Top

Published in:

01-10-2016 | Original Article

Patterns of Primary Immunodeficiency Disorders Among a Highly Consanguineous Population: Cairo University Pediatric Hospital’s 5-Year Experience

Authors: Nermeen Galal, Safa Meshaal, Rabab Elhawary, Dalia Abd ElAziz, Radwa Alkady, Sohilla Lotfy, Alia Eldash, Jeanette Boutros, Aisha Elmarsafy

Published in: Journal of Clinical Immunology | Issue 7/2016

Abstract

Introduction

Primary immunodeficiency disorders (PIDs) are heterogeneous disorders that mainly present with severe, persistent, unusual, or recurrent infections in childhood. Reports from different parts of the world indicate a difference between Western and Eastern populations.

Aim

The aim of this study was to report on the different patterns of PIDs and identify subgroup characteristics in a highly consanguineous population in Egypt.

Methods

We performed a retrospective chart review for children below 18 years diagnosed with PID at Cairo University Pediatric Hospital from 2010 to 2014.

Results

Four hundred seventy-six children were diagnosed with PID disorders. Major categories included combined immunodeficiency disorders, which constituted a large proportion (30 %) of cases, along with predominantly antibody disorders (18 %) followed by syndromic combined disorders (16.8 %), phagocytic disorders (13.2 %), immune dysregulation disorders (10.5 %), and autoinflammatory disorders (9 %).

Conclusion

PIDs have different patterns within inbred populations with high consanguinity.

Barbouche MR, Galal N, Ben-Mustapha I, Jeddane L, Mellouli F, Ailal F, et al. Primary immunodeficiencies in highly consanguineous North African populations. Ann N Y Acad Sci. 2011;1238:42–52.CrossRefPubMed

Al-Herz W, Aldhekri H, Barbouche MR, Rezaaei N. Consanguinity and primary immunodeficiencies. Hum Hered. 2014;77(1–4):138–43.CrossRefPubMed

Shawky RM, ElAwady M, Elsayed S, Hamadan G. Consanguinous matings among Egyptian population. Egypt J Med Hum Genet. 2012;12(2):157–63.CrossRef

Temtamy S, Aglan M. Consanguinity and genetic disorders in Egypt. Middle East J Med Genet. 2011;1(1):12–7.CrossRef

Anwar WA, Khayatti M, Hemminki K. Consanguinity and genetic diseases in North Africa and immigrants to Europe. Eur J Public Health. 2014;24 Suppl 1:57–63.CrossRefPubMed

Bashamboo A, McElreavey K. Consanguinity and disorders of sex development. Hum Hered. 2014;77(1–4):108–17.CrossRefPubMed

Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. 2015;35(8):696–726.CrossRefPubMedPubMedCentral

Meshaal S., El Hawary R., Elsharkawy M., Mousa R., Farid R., Abd. Elaziz D, Alkady R, Galal N., Massaad M, Boutros J., El Marsafy A. Mutations in recombination activating gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt. Clin Immunol. 2015; 158: 167–172

Al-Saud B, Al-Mousa H, Al Gazlan S, Al-Ghonaium A, Arnaout R, Al-Seraihy A, et al. Primary immunodeficiency diseases in Saudi Arabia: a tertiary care hospital experience over a period of three years (2010–2013). J Clin Immunol. 2015;35(7):651–60.CrossRefPubMed

10.

Azarsiz E, Gulez N, Karaca NE, Aksu G, Kutukculer N. Consanguinity rate and delay in diagnosis inTurkish patients with combined immunodeficiencies: a single center study. J Clin Immunol. 2011;31:106–11.CrossRefPubMed

11.

Mellouli F, Mustapha IB, Khaled MB, Besbes H, Ouederni M, Mekki N, et al. Report of the Tunisian Registry of Primary Immunodeficiencies: 25-Years of Experience (1988–2012). J Clin Immunol. 2015;35(8):745–53.CrossRefPubMed

12.

Bousfiha AA, Jeddane L, El Hafidi N, Benajiba N, Rada N, El Bakkouri J, et al. First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998–2012). J Clin Immunol. 2014;34:459–68.PubMed

13.

Al –Herz W. Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry. J Clin Immunol. 2008;28(2):186–93.CrossRefPubMed

14.

Al Khatib S, Keles S, Garcia-Lloret M, Karakoc-Aydiner E, Reisli I, Artac H, et al. Defects along the Th17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. J Allergy Clin Immunol. 2009;124(2):342–8.CrossRefPubMed

15.

Kilic S, Ozel M, Hafizoglu D, Karaca NE, Asku G, Kutukculer N. The prevalence and patient characteristics of primary immunodeficiency diseases in Turkey—two centers study. J Clin Immunol. 2013;33:74–83.CrossRefPubMed

16.

Köker MY, Camcıoğlu Y, van Leeuwen K, Kılıç SŞ, Barlan I, Yılmaz M, et al. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. J Allergy Clin Immunol. 2013;132(5):1156–63.CrossRefPubMed

17.

Al-Tamemi S, Elnour I, Dennison D. Primary immunodeficiency diseases in Oman: five years’ experience at Sultan Qaboos University Hospital. World Allergy Organ J. 2012;5(5):52–6.CrossRefPubMedPubMedCentral

18.

Reda SM, Afifi HM, Amine MM. Primary immunodeficiency diseases in Egyptian children: a single-center study. J Clin Immunol. 2009;29(3):343–51.CrossRefPubMed

19.

Al-Herz W, Notarangelo LD, Sadek A, Buckley R, USIDNET Consortium. Combined Immunodeficiency in the United States and Kuwait: comparison of patients’characteristics and molecular diagnosis. Clin Immunol. 2015;161(2):170–3.CrossRefPubMedPubMedCentral

20.

Wolach B, Gavrieli R, de Boer M, Gottesman G, Ben-Ari J, Rottem M, et al. Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients. Clin Immunol. 2008;129:103–14.CrossRefPubMed

21.

Rawat A, Singh S, Suri D, Gupta A, Saikia B, Minz RW, et al. Chronic granulomatous disease: Two decades of experience from a tertiary care center in North West India. J Clin Immunol. 2014;34(1):58–67.CrossRefPubMed

22.

Winkelstein JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155–69.CrossRef

23.

Gathmann B, Grimbacher B, Beaute J, Dudoit Y, Mahlaoui N, Fischer A, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2006–2008. Clin Exp Immunol. 2009;157 Suppl 1:3–11.CrossRefPubMedPubMedCentral

24.

El-Garf A, Salah S, Iskander I, Salah H, Amin SN. MEFV mutations in Egyptian patients suffering from familial Mediterranean fever analysis of 12 gene mutations. Rheumatol Int. 2010;30(10):1293–8.CrossRefPubMed

25.

Galal N, Boutros J, Marsafy A, Kong XF, Feinberg J, Casanova JL, et al. Mendelian susceptibility to mycobacterial disease in Egyptian children. Mediterr J Hematol Infect Dis. 2012;4(1), e2012033.CrossRefPubMedPubMedCentral

26.

Elloumi-Zghal H, Barbouche MR, Chemli J, Bejaoui M, Harbi A, Snoussi N, et al. Clinical and genetic heterogeneity of inherited autosomal recessive susceptibility to disseminated Mycobacterium bovis Bacille Calmette-Guérin infection. J Infect Dis. 2002;185:1468–75.CrossRefPubMed

Title: Patterns of Primary Immunodeficiency Disorders Among a Highly Consanguineous Population: Cairo University Pediatric Hospital’s 5-Year Experience
Authors: Nermeen Galal
Safa Meshaal
Rabab Elhawary
Dalia Abd ElAziz
Radwa Alkady
Sohilla Lotfy
Alia Eldash
Jeanette Boutros
Aisha Elmarsafy
Publication date: 01-10-2016
Publisher: Springer US
Published in: Journal of Clinical Immunology / Issue 7/2016
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-016-0314-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Aim

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 7/2016

Severe Early-Onset Combined Immunodeficiency due to Heterozygous Gain-of-Function Mutations in STAT1

Lymphoma Secondary to Congenital and Acquired Immunodeficiency Syndromes at a Turkish Pediatric Oncology Center

Long-Term Outcomes of Hematopoietic Stem Cell Transplantation for ZAP70 Deficiency

Brain Abscess in a Child with Leukocyte Adhesion Defect: An Unusual Association

Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome

Thoracic Surgery in Chronic Granulomatous Disease: a 25-Year Single-Institution Experience

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials